Prosecution Insights
Last updated: July 29, 2026
Application No. 18/469,328

FACILITATING TELEMETRY DATA COMMUNICATION SECURITY BETWEEN AN IMPLANTABLE DEVICE AND AN EXTERNAL DEVICE

Final Rejection §101§112§DP
Filed
Sep 18, 2023
Priority
Jul 27, 2016 — continuation of 10/576,290 +1 more
Examiner
GEDEON, BRIAN T
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Medtronic Inc.
OA Round
2 (Final)
87%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
94%
With Interview

Examiner Intelligence

Grants 87% — above average
87%
Career Allowance Rate
1183 granted / 1357 resolved
+17.2% vs TC avg
Moderate +7% lift
Without
With
+7.3%
Interview Lift
resolved cases with interview
Typical timeline
2y 6m
Avg Prosecution
40 currently pending
Career history
1388
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
48.8%
+8.8% vs TC avg
§102
7.9%
-32.1% vs TC avg
§112
1.3%
-38.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1357 resolved cases

Office Action

§101 §112 §DP
DETAILED ACTION Response to Amendment This action is in response to the amendment after non-final filed 26 January 2026. Claims 1-20 are pending. Claim Rejections - 35 USC § 101 The rejection of claim 20 has been withdrawn in view of Applicant’s amendment. Claim Rejections - 35 USC § 112 The rejection of claims 1, 12, and 20 for being indefinite had been withdrawn in view of Applicant’s amendment. Response to Arguments Applicant’s arguments filed with respect to the 35 USC 103 rejection of the claims as being unpatentable under Arx et al. (US Publication no. 2004/0260363) in view of Roberts et al. (US Publication no. 2012/0271380) have been fully considered and are persuasive. The prior art is found deficient in teaching the feature that activates, based on sending the session information according to the first telemetry communication protocol, the second communication circuitry. Therefore, the rejections have been withdrawn. Double Patenting The non-statutory double patenting rejection set forth in the previous Office action has been reviewed and is hereby MAINTAINED. A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Allowable Subject Matter Claims 1-20 would be allowable should Applicant’s reply with comply with or specifically traverse the requirements of the non-statutory double patenting rejection. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to BRIAN T GEDEON whose telephone number is (571)272-3447. The examiner can normally be reached M-F 8:00 am to 5:30 PM ET. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David E. Hamaoui can be reached at 571-270-5625. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BRIAN T GEDEON/Primary Examiner, Art Unit 3796 20 May 2026
Read full office action

Prosecution Timeline

Sep 18, 2023
Application Filed
Oct 28, 2025
Non-Final Rejection mailed — §101, §112, §DP
Jan 06, 2026
Interview Requested
Jan 16, 2026
Applicant Interview (Telephonic)
Jan 16, 2026
Examiner Interview Summary
Jan 26, 2026
Response Filed
May 26, 2026
Final Rejection mailed — §101, §112, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12691287
LEAD POSITIONING FOR AN IMPLANTABLE PULSE GENERATOR
3y 1m to grant Granted Jul 28, 2026
Patent 12685489
METHODS AND SYSTEMS FOR DETECTING ECG ANOMALIES
3y 3m to grant Granted Jul 21, 2026
Patent 12685867
SYSTEMS AND METHODS FOR MITIGATING STIMULATION CURRENT SPIKES AND GLITCHES IN NEUROSTIMULATION SYSTEMS
3y 0m to grant Granted Jul 21, 2026
Patent 12678623
SYSTEM AND METHOD TO SELECT AMONG TRAJECTORIES FOR THERAPEUTIC STIMULATION OF A TARGET VOLUME REGION WITHIN THE BRAIN
2y 9m to grant Granted Jul 14, 2026
Patent 12678098
FINGER WEARABLE HEALTH MONITORING DEVICE
3y 0m to grant Granted Jul 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
87%
Grant Probability
94%
With Interview (+7.3%)
2y 6m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1357 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month